Medicaid Expansion and Stage at Diagnosis, Timely Initiation and Receipt of Guideline-Concordant Treatment, and Survival Among People With Non–Small Cell Lung Cancer
Medicaid expansion was associated with improvements in early detection, timeliness of guideline-concordant treatment, and survival for people with NSCLC. Anticipated Medicaid coverage losses may jeopardize these gains.
Authors
- Jingxuan Zhao (ORCID: https://orcid.org/0000-0002-2733-2000)
- L. Zhang
- Xiao Hu (ORCID: https://orcid.org/0000-0001-9036-8455)
- Xuesong Han
- Ilana Graetz
- K. Robin Yabroff
- David Howard
- Joseph Lipscomb
Institutions
- Tufts University (US)
- American Cancer Society (US)
- Maine Medical Center (US)
- Emory University (US)
- Maine Medical Center (US)
- Clemson University (US)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2026-02-13
- DOI
- https://doi.org/10.1200/jco-25-01892
- Primary Topic
- Advanced Causal Inference Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00